Cargando…
Immune Checkpoint Inhibitor Therapy: A Boon to Elderly Patients with Advanced Melanoma?
Autor principal: | Muta, Tsuyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148169/ https://www.ncbi.nlm.nih.gov/pubmed/29607967 http://dx.doi.org/10.2169/internalmedicine.0686-17 |
Ejemplares similares
-
The neurotoxic effects of immune checkpoint inhibitor therapy for melanoma
por: Spain, Lavinia, et al.
Publicado: (2019) -
Advanced Research on Immune Checkpoint Inhibitor Therapy
por: Imai, Hisao, et al.
Publicado: (2022) -
Ketogenic diets: Boon or bane?
por: Shilpa, Joshi, et al.
Publicado: (2018) -
Combination strategies incorporating oncolytic viruses and immune checkpoint inhibitors for advanced melanoma: what is the evidence?
por: Wongariyapak, Amarin, et al.
Publicado: (2023) -
Low vision aids: A boon
por: Natarajan, Sundaram
Publicado: (2013)